technology commercialization
CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.
Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test
The companies will combine the Binx io diagnostic platform with Sherlock Bio's CRISPR technology to create an easy-to-use rapid test for the point of care.
CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test
The partners are planning to develop and commercialize UroMap, a urine-based gene-expression test for acute cellular rejection in kidney transplant recipients.
Companies in the AMR space have met resistance from investors and clinicians as a result of conflicting hospital priorities and perceived technology shortcomings.
Illumina, Adaptive Biotechnologies Partner on IVD Test Kits for Immune Sequencing
Seattle-based Adaptive will develop in vitro diagnostic test kits for distribution, which will run on Illumina's NextSeq 550 Dx system.